Documento sin título
  NEW PRODUCT  

5 mg and 10 mg Prasugrel, platelet inhibitor

A P2Y12 platelet inhibitor indicated with aspirin for the reduction of thrombotic cardiovascular events (including stent thrombosis) in patients with acute coronary syndrome who are to be managed with PCI

 
 
Related Bibliography  
     
BACK TO NEWS LIST  
Documento sin título